China's National Medical Products Administration has approved a Phase III trial of InnoCare Pharma’s ICP-248 (Mesutoclax) ...

Apoptosis can be triggered by the immune system or by the interaction of viral proteins with host signalling pathways. Inhibition of apoptosis has mixed effects on viral titre but typically has a ...

Imatinib-induced apoptosis was abrogated in LynΔN-overexpressing ... Importantly, the protective effect of LynΔN was suppressed by two inhibitors of Lyn activity. LynΔN also inhibits imatinib ...

The following is a summary of “Role of NAT10-mediated ac4C acetylation of ENO1 mRNA in glycolysis and apoptosis in non-small ...

In addition, the company is developing APG-1387, a small molecule inhibitor of apoptosis proteins for advanced solid tumors and chronic HBV infection; APG-2449, an oral inhibitor of FAK ...

Miyazaki discovered a protein called “apoptosis inhibitor of macrophage” (AIM), which exists in the blood of many animal species. He found in 2016 that AIM does not work properly in the ...

Apoptosis Market size is expected to reach ... accepted the New Drug Application for lisaftoclax, a Bcl-2 selective inhibitor for treating chronic lymphocytic leukemia/small lymphocytic lymphoma.

DelveInsight’s, “HDAC Inhibitor Pipeline Insight” report provides comprehensive insights about 40+ companies and 50+ pipeline ...